RHOA and adult T-cell leukemia/lymphoma: Gain-of-function mutations of RHOA have been described at lower frequencies in human tumors, such as RHOA A161V/P in bladder urothelial cancer and RHOA C16 and A161V/P in adult T-cell leukemia/lymphoma (see specific paragraph in this review) [28,29].